SCHEMBL20737205

SCHEMBL20737205

c1ccc(-c2nc3ccccc3n2-c2ccc(-c3cc4c(c5ccccc35)-c3cc5ccccc5cc3C43c4ccccc4-c4ccccc43)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.46
ESR2 Q92731 2/20 0.46
GRIA1 P42261 1/20 0.40
CACNG8 Q8WXS5 1/20 0.40
CACNG2 Q9Y698 1/20 0.40
PTGS2 P35354 1/20 0.37
ALDH1A1 P00352 5/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
HSP90AA1 P07900 1/20 0.36
MAPT P10636 1/20 0.36
RECQL P46063 1/20 0.36
HDAC1 Q13547 3/20 0.36
HDAC8 Q9BY41 3/20 0.36
HDAC6 Q9UBN7 3/20 0.36
RAB9A P51151 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
AKT1 P31749 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20736629 0.97 ESR1 (0.41) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL20736544 0.91 ESR1 (0.40) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL20737237 0.91 ESR1 (0.40) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL20737200 0.90 SIRT2 (0.37) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL20737204 0.89 MAPK1 (0.43) GRIA1CACNG8CACNG2ALDH1A1KDM4E
SCHEMBL27250491 0.89 ESR1 (0.46) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL11914270 0.87 ESR1 (0.41) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL27250529 0.87 ESR1 (0.43) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL20737174 0.87 ESR1 (0.44) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL20737207 0.87 PDE10A (0.37) ESR1ESR2GRIA1CACNG8CACNG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 ESR1 2/4885ESR2 10/4885GRIA1 366/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 ESR1 2/4885ESR2 10/4885GRIA1 366/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 ESR1 2/4885ESR2 10/4885GRIA1 366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.